Riverbridge Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-16,581
Closed -$740K 133
2018
Q4
$740K Sell
16,581
-10,359
-38% -$540K 0.02% 112
2018
Q3
$1.46M Sell
26,940
-516
-2% -$26.4K 0.02% 108
2018
Q2
$1.34M Sell
27,456
-2,859
-9% -$162K 0.02% 106
2018
Q1
$1.9M Buy
30,315
+2,579
+9% +$177K 0.03% 104
2017
Q4
$1.7M Buy
27,736
+8,037
+41% +$497K 0.03% 107
2017
Q3
$1.32M Sell
19,699
-174
-0.9% -$12.3K 0.03% 109
2017
Q2
$1.55M Sell
19,873
-473
-2% -$35.7K 0.03% 109
2017
Q1
$1.66M Buy
20,346
+1,350
+7% +$106K 0.03% 106
2016
Q4
$1.37M Sell
18,996
-1,676
-8% -$121K 0.03% 111
2016
Q3
$1.61M Buy
20,672
+335
+2% +$27.1K 0.03% 105
2016
Q2
$1.59M Buy
20,337
+309
+2% +$24.6K 0.03% 106
2016
Q1
$1.64M Buy
20,028
+1,822
+10% +$148K 0.03% 106
2015
Q4
$1.63M Buy
18,206
+6,420
+54% +$545K 0.03% 108
2015
Q3
$905K Buy
+11,786
New +$985K 0.02% 110

Other funds holding CAH

Riverbridge Partners's CAH Position: Q1 2019 in Review

Riverbridge Partners sold out of Cardinal Health (CAH) in Q1 2019, closing a stake of 16,581 shares — an estimated $740K sold.

Riverbridge Partners first reported a position in CAH in Q3 2015 and held it in 14 quarters. The position peaked at $1.9M in Q1 2018. 693 funds tracked by Wall St. Rank hold CAH as of Q1 2019.

  • Riverbridge Partners reported no remaining Cardinal Health position as of Q1 2019 after selling out during the quarter.
  • Riverbridge Partners sold 16,581 Cardinal Health shares in Q1 2019, an estimated $740K.
  • Riverbridge Partners first reported a position in Cardinal Health in Q3 2015 and held it in 14 quarters.
  • Riverbridge Partners's Cardinal Health position peaked at $1.9M in Q1 2018.
  • 693 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2019.

Based on Riverbridge Partners's 13F filing for Q1 2019, filed 4 Apr 2019.